Ataxin 1 Monoclonal Antibody (2F5), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA515735-Each-of-1 | In Stock | ₹ 52,554.50 |
PIMA515735 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 52,554.50
GST (18%): ₹ 9,459.81
Total Price: ₹ 62,014.31
Antigen
Ataxin 1
Classification
Monoclonal
Concentration
Conc. Not Determined
Formulation
ascites with 0.03% sodium azide
Gene Accession No.
P54253, P54254, Q63540
Gene Symbols
ATXN1
Immunogen
Purified recombinant fragment of human ATXN1 expressed in E. Coli.
Regulatory Status
RUO
Gene ID (Entrez)
20238, 25049, 6310
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
ELISA, Flow Cytometry, Immunocytochemistry, Immunohistochemistry, Western Blot
Clone
2F5
Conjugate
Unconjugated
Gene
ATXN1
Gene Alias
2900016G23Rik; alternative ataxin1; ataxin 1; Ataxin1; ataxin-1; Atx1; Atx-1; Atx-1-PB; Atxn1; C85907; CG4547; CG4547-PB; D6S504E; dAtx-1; Dmel\CG4547; Dmel_CG4547; ENSMUSG00000074917; Gm10786; OTTHUMP00000016065; SCA1; spinocerebellar ataxia 1; spinocerebellar ataxia 1 homolog; spinocerebellar ataxia type 1 protein; Spinocerebellar ataxia type 1 protein homolog
Host Species
Mouse
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG1
Related Products
Description
- MA5-15735 targets ATXN1 in indirect ELISA, FACS, IF, IHC, and WB applications and shows reactivity with Human samples
- The MA5-15735 immunogen is purified recombinant fragment of human ATXN1 expressed in E
- Coli
- MA5-15735 detects ATXN1 which has a predicted molecular weight of approximately 87kDa
- The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord
- Clinically, ADCA has been divided into three groups: ADCA types I-III
- ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes
- ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders
- Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions
- ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein
- The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations
- The function of the ataxins is not known
- This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 41-81 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1)
- At least two transcript variants encoding the same protein have been found for this gene.